China Reinsurance (Group) Corporation (China Re) released its unaudited results for the first half of 2025, reporting a net profit of RMB 6,599 million, up 11.4% from RMB 5,922 million in the same period a year earlier.
Insurance revenue amounted to RMB 51,056 million, down 1.4% from RMB 51,784 million, while investment income rose to RMB 4,256 million from RMB 3,821 million.
Operating income increased slightly by 0.6% to RMB 61,028 million from RMB 60,686 million, with total income amounting to RMB 61,028 million, compared to RMB 60,686 million a year earlier.
Breaking down its results by segment, the company’s P&C reinsurance business posted a net profit of RMB 2,338 million in H1’25, a 9.3% decline from RMB 2,579 million in H1’24.
-->
Insurance revenue fell 2.2% to RMB 22,959 million from RMB 23,474 million, mainly due to a decline in earned premiums from the domestic agriculture insurance business.
Interest income rose 4% to RMB 1,523 million from RMB 1,465 million, while investment income decreased 18.7% to RMB 1,045 million from RMB 1,286 million.
Total income for the P&C reinsurance segment was RMB 26,199 million, slightly down from RMB 26,233 million.
For its life and health reinsurance business, net profit amounted to RMB 2,853 million, up 13.6% from RMB 2,511 million.
Insurance revenue for the segment was RMB 4,738 million, down 19.2% from RMB 5,861 million, accounting for 9.1% of the Group’s insurance revenue. The decrease was mainly due to lower protection-type business.
Interest income fell 2.4% to RMB 2,251 million from RMB 2,307 million, while investment income rose 43.2% to RMB 2,551 million from RMB 1,782 million, mainly due to changes in the capital market.
Total income for China Re’s life and health segment was RMB 9,600 million, a 4.1% decline from RMB 10,007 million a year earlier.
About the Author
